Amgen Inc . (NASDAQ:AMGN), a leading biopharmaceutical company with a market capitalization of $149 billion, is navigating a ...

This December, Amgen received a second state incentive to expand its Holly Springs operations by adding another drug ...

Amgen (Nasdaq: AMGN) has completed construction of a $550 million drug manufacturing facility in the Wake County town.

This was made possible by 10 products posting double-digit ... Another risk to Amgen is the potential that the drugs in its pipeline may not commercially materialize as expected.

Despite high debt from the Horizon Therapeutics acquisition, Amgen shows growth potential through obesity drugs, biosimilars ... we can look at already approved products with growth potential.

High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, ...

Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Amgen’s Imdylltra (tarlatamab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with small cell lung cancer (SCLC). The drug has been specifically ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made ...